HEART FAILURE NYHA CLASS III
Clinical trials for HEART FAILURE NYHA CLASS III explained in plain language.
Never miss a new study
Get alerted when new HEART FAILURE NYHA CLASS III trials appear
Sign up with your email to follow new studies for HEART FAILURE NYHA CLASS III, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Wireless Lung-Artery sensor could keep heart failure patients out of hospital
Disease control Recruiting nowThis trial tests a small sensor placed in the pulmonary artery (the blood vessel from the heart to the lungs) that wirelessly sends daily pressure readings to doctors. The goal is to help people with moderate heart failure (NYHA Class II or III) manage their condition at home and…
Matched conditions: HEART FAILURE NYHA CLASS III
Phase: NA • Sponsor: Endotronix, Inc. • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Smart watch for the heart: can remote monitoring save lives?
Disease control Recruiting nowThis study tests a new remote monitoring system called SmartSignalHF in 1132 adults with heart failure who have an implanted heart device (ICD or CRT-D). The goal is to see if this system can reduce deaths and hospital stays over 12 months compared to standard care. Participants …
Matched conditions: HEART FAILURE NYHA CLASS III
Phase: NA • Sponsor: Implicity • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Lab-Grown heart cells tested in humans for first time
Disease control Recruiting nowThis early-stage trial tests whether heart cells grown from a patient's own stem cells are safe to inject into people with severe congenital heart disease. About 50 participants will receive the cells or be in a control group. The main goal is to check for serious side effects wi…
Matched conditions: HEART FAILURE NYHA CLASS III
Phase: PHASE1 • Sponsor: HeartWorks, Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New device combo aims to ease heart failure burden
Disease control Recruiting nowThis study tests if using two devices together can help people with advanced heart failure. Participants get a CardioMems sensor to monitor heart pressure and later a BaroStim device to regulate blood pressure. The goal is to improve symptoms, walking ability, and reduce hospital…
Matched conditions: HEART FAILURE NYHA CLASS III
Phase: PHASE2, PHASE3 • Sponsor: Northwell Health • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Heart failure patients get a High-Tech watchdog: implanted sensor aims to cut hospital visits
Disease control Recruiting nowThis study will compare two groups of people with chronic heart failure: those who receive the Cordella PA Sensor System (an implanted device that monitors pressure in the lung artery) and those who get standard medication alone. Researchers will track about 2,150 participants fo…
Matched conditions: HEART FAILURE NYHA CLASS III
Sponsor: Endotronix, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Can a phone call a week help heart patients live better?
Symptom relief Recruiting nowThis study tests a 12-week phone program that uses positive psychology and motivational interviewing to help 280 heart failure patients stick to their diet, exercise, and medications. Participants get weekly phone sessions and text messages. The goal is to see if this approach im…
Matched conditions: HEART FAILURE NYHA CLASS III
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC
-
New study brings palliative care to rural heart failure Patients' doorsteps
Symptom relief Recruiting nowThis study tests a nurse-led home care program for people with advanced heart failure and their family caregivers in rural Appalachia. The program uses faith-based nurses and local volunteers to improve quality of life and reduce symptoms. About 208 patients and their caregivers …
Matched conditions: HEART FAILURE NYHA CLASS III
Phase: NA • Sponsor: West Virginia University • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC